NRIP3 | Nuclear receptor interacting protein 3 | | | | | | Group enriched |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
RD3 | Retinal degeneration 3 | Disease related genes
| | | | | Tissue enriched |
SCG2 | Secretogranin II | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
STAR | Steroidogenic acute regulatory protein | Disease related genes Mitochondrial proteins
| | | | | Tissue enriched |
STMN2 | Stathmin-like 2 | | | | | | Group enriched |
SYNGR3 | Synaptogyrin 3 | Predicted membrane proteins
| | | | | Group enriched |
TMEM179 | Transmembrane protein 179 | Predicted membrane proteins
| | | | | Group enriched |
UCHL1 | Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
AC011239.1 | Uncharacterized protein | | | | | | Group enriched |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
BRINP2 | Bone morphogenetic protein/retinoic acid inducible neural-specific 2 | Predicted secreted proteins
| | | | | Group enriched |
DLX1 | Distal-less homeobox 1 | Transcription factors
| | | | | Group enriched |
FAM43B | Family with sequence similarity 43, member B | | | | | | Tissue enriched |
GRIK1 | Glutamate receptor, ionotropic, kainate 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
KCNK9 | Potassium channel, subfamily K, member 9 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
LUZP2 | Leucine zipper protein 2 | Predicted secreted proteins
| | | | | Group enriched |
NR5A1 | Nuclear receptor subfamily 5, group A, member 1 | Disease related genes Nuclear receptors Transcription factors
| | | | | Group enriched |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
RET | Ret proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
SHANK1 | SH3 and multiple ankyrin repeat domains 1 | Plasma proteins
| | | | | Group enriched |
SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | Plasma proteins RAS pathway related proteins
| | | | | Group enriched |
SIGLEC11 | Sialic acid binding Ig-like lectin 11 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ST8SIA5 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 | Predicted membrane proteins
| | | | | Group enriched |
ZIM2 | Zinc finger, imprinted 2 | Transcription factors
| | | | | Group enriched |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC009060.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC115618.1 | Uncharacterized protein; cDNA FLJ26048 fis, clone PRS02384 | | | | | | Tissue enhanced |
AC120194.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
ADAMTSL2 | ADAMTS-like 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGRP | Agouti related protein homolog (mouse) | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AMHR2 | Anti-Mullerian hormone receptor, type II | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ANO4 | Anoctamin 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
AP000350.10 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AP001579.1 | Uncharacterized protein | | | | | | Tissue enhanced |
ARC | Activity-regulated cytoskeleton-associated protein | | | | | | Tissue enhanced |
ASTN1 | Astrotactin 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AVPR1A | Arginine vasopressin receptor 1A | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C19orf26 | Chromosome 19 open reading frame 26 | Predicted membrane proteins
| | | | | Tissue enhanced |
C1QTNF1-AS1 | C1QTNF1 antisense RNA 1 | | | | | | Tissue enhanced |
C2orf66 | Chromosome 2 open reading frame 66 | Predicted secreted proteins
| | | | | Tissue enhanced |
C7 | Complement component 7 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C9orf47 | Chromosome 9 open reading frame 47 | Predicted secreted proteins
| | | | | Tissue enhanced |
CABP7 | Calcium binding protein 7 | Predicted membrane proteins
| | | | | Tissue enhanced |
CALN1 | Calneuron 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CBLN4 | Cerebellin 4 precursor | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CNGB1 | Cyclic nucleotide gated channel beta 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |